# OnCo record amgen (company). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/companies/amgen/>
  a schema:Organization ;
  onco:kind "company" ;
  schema:identifier "amgen" ;
  schema:name "Amgen"@en ;
  schema:alternateName "BioVex Limited"@en, "BioVex"@en ;
  schema:description "Amgen invented the BiTE T-cell engager format and the first KRAS inhibitor."@en ;
  schema:url <https://onco.cc/companies/amgen/>, <https://www.amgen.com> ;
  schema:dateModified "2026-09-04"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Amgen> ;
  owl:sameAs <http://www.wikidata.org/entity/Q470517> ;
  schema:citation <https://www.amgen.com> ;
  schema:addressCountry "US" ;
  onco:sections <https://onco.cc/fronts/immunotherapy/>, <https://onco.cc/fronts/targeted-therapy/> ;
  onco:drugs <https://onco.cc/drugs/blinatumomab/>, <https://onco.cc/drugs/tarlatamab/>, <https://onco.cc/drugs/sotorasib/>, <https://onco.cc/drugs/talimogene-laherparepvec/>, <https://onco.cc/drugs/anvumetostat/>, <https://onco.cc/drugs/cinacalcet/> ;
  onco:trials <https://onco.cc/trials/nct05920356/>, <https://onco.cc/trials/nct06054555/>, <https://onco.cc/trials/nct06430866/>, <https://onco.cc/trials/nct07005128/>, <https://onco.cc/trials/nct06311721/>, <https://onco.cc/trials/nct07213674/>, <https://onco.cc/trials/nct06252649/>, <https://onco.cc/trials/nct06117774/>, <https://onco.cc/trials/nct07778316/>, <https://onco.cc/trials/nct06502977/>, <https://onco.cc/trials/nct05060016/>, <https://onco.cc/trials/nct06745323/>, <https://onco.cc/trials/nct04521231/>, <https://onco.cc/trials/nct05094336/>, <https://onco.cc/trials/nct06593522/>, <https://onco.cc/trials/nct07134088/>, <https://onco.cc/trials/nct03937154/>, <https://onco.cc/trials/nct07172919/> .